Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INCIRWD · Entity 5213 | Director | June 16, 2026 | June 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IRONWOOD PHARMACEUTICALS INC
Report date June 16, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 229,364 |
Reported balance
After 2026-06-16 transaction · row 1
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 63,481 · Balance 229,364 F1: The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 17, 2026 20:45 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 63,481 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274292 · ownership.xml · nonDerivative · entry 1 Kessler Marla L · CIK 0001772124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,364 F1 · kind: The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085452 · ownership.xml · nonDerivative · entry 1 Kessler Marla L · CIK 0001772124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,883 F1 · kind: The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 20:05 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 24,311 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076207 · ownership.xml · nonDerivative · entry 1 Kessler Marla L · CIK 0001772124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,883 F1 · kind: The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:09 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | SaleClass A Common Stock | 9,926 | $11.19 | $111,071.94 |
DisclosureSEC source: 0001209191-23-058948 · doc4.xml · nonDerivative · entry 1 Kessler Marla L · CIK 0001772124 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,572 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 7, 2023, to satisfy tax obligations in connection with the vesting of 21,571 restricted stock awards on June 19, 2023. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 21:29 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 22,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-039136 · doc4.xml · nonDerivative · entry 1 Kessler Marla L · CIK 0001772124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,498 F1 · kind: The restricted stock, granted pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:05 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | SaleClass A Common Stock | 7,610 | $11.65 | $88,656.50 |
DisclosureSEC source: 0001209191-22-037400 · doc4.xml · nonDerivative · entry 1 Kessler Marla L · CIK 0001772124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,148 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:05 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 21,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033968 · doc4.xml · nonDerivative · entry 1 Kessler Marla L · CIK 0001772124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,758 F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:10 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 22,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038195 · doc4.xml · nonDerivative · entry 1 Kessler Marla L · CIK 0001772124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,187 F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:34 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 21,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034695 · doc4.xml · nonDerivative · entry 1 Kessler Marla L · CIK 0001772124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,421 F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:09 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 22,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033627 · doc4.xml · nonDerivative · entry 1 Kessler Marla L · CIK 0001772124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,701 F1 · kind: The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 22:42 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 2,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023459 · doc4.xml · nonDerivative · entry 1 Kessler Marla L · CIK 0001772124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,995 F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.